Rational Design of Asymmetric Polymethines to Attain NIR(II) Bioimaging at >1100 nm

Organic molecules exhibiting fluorescence in the Second Near-Infrared (NIR-II) window represent a burgeoning frontier in high-resolution biological imaging due to reduced tissue scattering and autofluorescence. Prior research has shown that achieving significant emission intensity in this spectral range remains difficult due to non-radiative decay pathways governed by the energy gap law. This physical principle dictates that internal conversion processes dominate when the energy gap between electronic states decreases, leading to quenched fluorescence in long-wavelength dyes. Molecular vibrations and the associated internal reorganization energy (Λint) serve as primary drivers for these efficiency losses in organic fluorophores during electronic relaxation. While symmetric polymethine structures minimize these losses by reducing vibrational modes, the requirement for structural symmetry restricts the chemical diversity and functional versatility of available dyes. This constraint prevents the integration of multiple targeting ligands or specialized chemical sensors into a single molecular scaffold for complex diagnostic tasks. This absence of evidence motivated the exploration of alternative molecular architectures that maintain low vibrational energy loss without strict symmetry constraints.

Researchers investigated a novel molecular design strategy to develop asymmetric polymethines capable of efficient emission beyond 1100 nanometers for deep-tissue imaging and diagnostic applications. The team hypothesized that maintaining equal transition density between two distinct terminal chromophores would minimize the internal reorganization energy (Λint) to levels seen in symmetric molecules. This approach aimed to replicate the photophysical advantages of symmetric dyes while expanding the structural library of Near-Infrared II (NIR-II) emitters for broader biomedical use. The study sought to validate this concept by synthesizing specific molecules terminated with xanthen-9-yl-benzoic acid and 2,4-diphenylthiopyrylium derivatives to observe their optical behavior. By comparing these new asymmetric variants to established symmetric counterparts, the scientists intended to demonstrate superior quantum yields and improved brightness for biological detection. The project also evaluated the practical utility of these dyes for targeted biological imaging applications in living systems, specifically focusing on cancer and skeletal visualization.

The investigators synthesized a library of asymmetric polymethines, specifically identifying AJBF1112 and AEBF1119 as primary candidates for high-performance bioimaging in the infrared spectrum. These molecules featured a core structure linked to xanthen-9-yl-benzoic acid and 2,4-diphenylthiopyrylium moieties to test the transition density hypothesis under experimental conditions. Computational modeling using density functional theory was employed to calculate the internal reorganization energy (Λint) for both asymmetric and symmetric reference compounds to predict efficiency. The researchers measured the photoluminescence spectra and quantum yields of the novel dyes alongside symmetric derivatives labeled SC1162, 1182, 1185, and 1230 for comparative analysis. To facilitate biological testing, the AEBF1119 fluorophore was encapsulated into polymer dots for enhanced stability and biocompatibility in aqueous environments and physiological buffers. Experimental protocols included in vitro cellular imaging and in vivo assessments of tumor and bone targeting using the Second Near-Infrared (NIR-II) detection window.

The asymmetric polymethines AJBF1112 and AEBF1119 exhibited peak emission wavelengths at 1112 nm and 1119 nm, respectively, placing them deep within the NIR-II region for optimal tissue penetration. Calculated internal reorganization energy (Λint) values reached as low as 6.2 kcal/mol for AJBF1112 and 7.3 kcal/mol for AEBF1119, confirming the theoretical predictions. These low energy values confirmed that the asymmetric design effectively suppressed internal conversion, matching the performance of symmetric structures while offering greater chemical flexibility. Both novel compounds demonstrated quantum yields exceeding those of all synthesized symmetric 2,4-diphenylthiopyrylium derivatives, including SC1162, 1182, 1185, and SC1230, during comparative fluorescence testing. The polymer dot formulation of AEBF1119 successfully enabled high-contrast specific cellular imaging during laboratory trials without significant cytotoxicity or photobleaching. In vivo experiments revealed that the AEBF1119-based nanoparticles effectively targeted tumor tissues and bone structures within the NIR-II spectral region, providing clear anatomical visualization.

The study establishes that asymmetric polymethines can achieve high emission efficiency in the Second Near-Infrared (NIR-II) region through rational transition density management between terminal groups. This design paradigm removes the historical necessity for molecular symmetry, allowing for a broader range of functionalized organic fluorophores in medical diagnostics and molecular biology. The findings suggest that minimizing internal reorganization energy (Λint) is the primary requirement for optimizing long-wavelength organic emitters, regardless of their symmetry or structural complexity. Future development of NIR-II dyes can now leverage diverse chromophores to tune biological targeting and photophysical properties simultaneously for precision medicine and real-time surgical guidance. The successful imaging of tumors and bones highlights the potential for these asymmetric dyes in clinical diagnostic applications and non-invasive monitoring of disease progression. These results provide a theoretical and practical framework for the next generation of high-performance organic contrast agents for deep-tissue optical imaging.